Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001808805-23-000013
Filing Date
2023-02-23
Accepted
2023-02-23 16:19:55
Documents
5
Effectiveness Date
2023-02-23

Document Format Files

Seq Description Document Type Size
1 S-8 forms-82023evergreen.htm S-8 79542
2 EX-FILING FEES exhibit107filingfeetables2.htm EX-FILING FEES 19709
3 EX-5.1 exhibit51wsgrlegalopinion2.htm EX-5.1 9703
4 EX-23.1 exhibit231consentofpricewa.htm EX-23.1 2523
5 GRAPHIC image_1.jpg GRAPHIC 74541
  Complete submission text file 0001808805-23-000013.txt   215225
Mailing Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102 206-333-2001
Nautilus Biotechnology, Inc. (Filer) CIK: 0001808805 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-269950 | Film No.: 23659925
SIC: 3826 Laboratory Analytical Instruments